首页> 外国专利> Homogeneous hydrochloride Crystalline polymorphs of N - (3-ethynylphenyl) - 6, 7 - bis - (2-methoxyethoxy) 4 quinazolinamina; Pharmaceutical compositions made with these polymorphs; use thereof in the preparation of these compositions, Process for the preparation of the Polymorph B

Homogeneous hydrochloride Crystalline polymorphs of N - (3-ethynylphenyl) - 6, 7 - bis - (2-methoxyethoxy) 4 quinazolinamina; Pharmaceutical compositions made with these polymorphs; use thereof in the preparation of these compositions, Process for the preparation of the Polymorph B

机译:N-(3-乙炔基苯基)-6、7-双-(2-甲氧基乙氧基)4喹唑啉氨基的均相盐酸盐多晶型物;用这些多晶型物制成的药物组合物;在制备这些组合物中的用途,制备多晶型物B的方法

摘要

The polymorphous salt of 1. N - (3-ethylphenyl) - 6, 7-Bis (2-methoxyformate) - 4-kundienylhydrazide is described and claimed to have stable polymorphous, characterized by being designated as' polymorphous B, characterized by an X-ray powder diffraction pattern of 2-titanium, expressed at a rate of about 6.26, 12.48, 13.39, 16.96, 20; 20. 21.10, 22.98, 24.46, 25.14 and 26.91. In addition, in the development of drugs for the treatment of extremely widespread diseases such as cancer and other items mentioned in the title, these applications are described and requirements are put forward.
机译:1.N-(3-乙基苯基)-6、7-双(2-甲氧基甲酸酯)-4-und二烯酰肼的多晶型盐被描述并声称具有稳定的多晶型物,其特征在于被称为'多晶型物B,其特征在于X -钛的X射线粉末衍射图,以约6.26、12.48、13.39、16.96、20的速率表示; 20. 21.10、22.98、24.46、25.14和26.91。另外,在开发用于治疗广泛传播的疾病(例如癌症和标题中提及的其他项目)的药物时,对这些应用进行了描述并提出了要求。

著录项

  • 公开/公告号AR035563A1

    专利类型

  • 公开/公告日2004-06-16

    原文格式PDF

  • 申请/专利权人 OSI PHARMACEUTICALS INC.;

    申请/专利号AR2000P105956

  • 发明设计人

    申请日2000-11-10

  • 分类号C07D239/94;A61K31/505;A61P35/00;

  • 国家 AR

  • 入库时间 2022-08-21 23:12:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号